154 related articles for article (PubMed ID: 2573056)
1. Interaction of glucagon-like peptide-1(7-36)amide and somatostatin-14 in RINm5F cells and in the perfused rat pancreas.
Göke R; Fehmann HC; Richter G; Trautmann M; Göke B
Pancreas; 1989; 4(6):668-73. PubMed ID: 2573056
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells.
Stark A; Mentlein R
Regul Pept; 2002 Oct; 108(2-3):97-102. PubMed ID: 12220732
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of glucagon-like peptide-1(7-36)amide: insulinotropic activities in perfused rat pancreases, and receptor binding and cyclic AMP production in RINm5F cells.
Watanabe Y; Kawai K; Ohashi S; Yokota C; Suzuki S; Yamashita K
J Endocrinol; 1994 Jan; 140(1):45-52. PubMed ID: 8138751
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K
Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338
[TBL] [Abstract][Full Text] [Related]
7. Signal transmission after GLP-1(7-36)amide binding in RINm5F cells.
Göke R; Trautmann ME; Haus E; Richter G; Fehmann HC; Arnold R; Göke B
Am J Physiol; 1989 Sep; 257(3 Pt 1):G397-401. PubMed ID: 2551182
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro.
Guenifi A; Ahrén B; Abdel-Halim SM
Pancreas; 2001 Jan; 22(1):58-64. PubMed ID: 11138972
[TBL] [Abstract][Full Text] [Related]
9. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
Fehmann HC; Habener JF
FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
[TBL] [Abstract][Full Text] [Related]
10. Interaction of glucagon-like peptide-I (7-37) and somatostatin-14 on signal transduction and proinsulin gene expression in beta TC-1 cells.
Fehmann HC; Strowski M; Göke B
Metabolism; 1994 Jun; 43(6):787-92. PubMed ID: 7911222
[TBL] [Abstract][Full Text] [Related]
11. Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells.
Göke R; Conlon JM
J Endocrinol; 1988 Mar; 116(3):357-62. PubMed ID: 2832504
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-I analogs: effects on insulin secretion and adenosine 3',5'-monophosphate formation.
Gefel D; Hendrick GK; Mojsov S; Habener J; Weir GC
Endocrinology; 1990 Apr; 126(4):2164-8. PubMed ID: 2156683
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells.
Gallwitz B; Schmidt WE; Conlon JM; Creutzfeldt W
J Mol Endocrinol; 1990 Aug; 5(1):33-9. PubMed ID: 2168708
[TBL] [Abstract][Full Text] [Related]
14. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
Inoue K; Hisatomi A; Umeda F; Nawata H
Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
[TBL] [Abstract][Full Text] [Related]
16. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide.
Komatsu R; Matsuyama T; Namba M; Watanabe N; Itoh H; Kono N; Tarui S
Diabetes; 1989 Jul; 38(7):902-5. PubMed ID: 2661287
[TBL] [Abstract][Full Text] [Related]
17. Solubilization of active GLP-1 (7-36)amide receptors from RINm5F plasma membranes.
Göke R; Oltmer B; Sheikh SP; Göke B
FEBS Lett; 1992 Apr; 300(3):232-6. PubMed ID: 1313374
[TBL] [Abstract][Full Text] [Related]
18. Internalization of glucagon-like peptide-1(7-36)amide in rat insulinoma cells.
Göke R; Richter G; Göke B; Trautmann M; Arnold R
Res Exp Med (Berl); 1989; 189(4):257-64. PubMed ID: 2554438
[TBL] [Abstract][Full Text] [Related]
19. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
Heller RS; Aponte GW
Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
[TBL] [Abstract][Full Text] [Related]
20. Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut.
Kreymann B; Ghatei MA; Domin J; Kanse S; Bloom SR
Endocrinology; 1991 Aug; 129(2):1001-5. PubMed ID: 1677327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
